Core Laboratories N.V.CLBNYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank21
3Y CAGR+1.6%
5Y CAGR-26.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+1.6%/yr
vs -12.2%/yr prior
5Y CAGR
-26.2%/yr
Recent acceleration
Acceleration
+13.8pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $39.21M | +31.5% |
| 2024 | $29.82M | -24.3% |
| 2023 | $39.41M | +5.4% |
| 2022 | $37.40M | -3.1% |
| 2021 | $38.58M | -78.4% |
| 2020 | $178.93M | +135.6% |
| 2019 | $75.95M | +20.7% |
| 2018 | $62.91M | +31.8% |
| 2017 | $47.74M | +21.2% |
| 2016 | $39.39M | - |